Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomePreferred Shares IssuedShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

vTv Therapeutics (VTVT) Long-Term Debt Issuances: 2014-2015

Historic Long-Term Debt Issuances for vTv Therapeutics (VTVT) over the last 1 years, with Sep 2015 value amounting to $13,000.

  • vTv Therapeutics' Long-Term Debt Issuances fell 99.74% to $13,000 in Q3 2015 from the same period last year, while for Sep 2015 it was $28.9 million, marking a year-over-year change of. This contributed to the annual value of $566,000 for FY2023, which is 27.06% down from last year.
  • Latest data reveals that vTv Therapeutics reported Long-Term Debt Issuances of $13,000 as of Q3 2015, which was down 99.88% from $10.5 million recorded in Q2 2015.
  • Over the past 5 years, vTv Therapeutics' Long-Term Debt Issuances peaked at $10.5 million during Q2 2015, and registered a low of $13,000 during Q3 2015.
  • In the last 2 years, vTv Therapeutics' Long-Term Debt Issuances had a median value of $8.8 million in 2015 and averaged $6.8 million.
  • Data for vTv Therapeutics' Long-Term Debt Issuances shows a maximum YoY plummeted of 99.74% (in 2015) over the last 5 years.
  • Quarterly analysis of 2 years shows vTv Therapeutics' Long-Term Debt Issuances stood at $9.7 million in 2014, then plummeted by 99.74% to $13,000 in 2015.
  • Its last three reported values are $13,000 in Q3 2015, $10.5 million for Q2 2015, and $8.8 million during Q1 2015.